OvaScience greenshoe exercised for $55.19 million public stock sale

Leerink Partners was bookrunner; deal funds preclinical studies

By Devika Patel

Knoxville, Tenn., March 18 - OvaScience, Inc. said the underwriters for its public offering of stock opted to exercise the deal's $7.5 million greenshoe in part, lifting total proceeds to $55.19 million. The offering was announced March 3 and priced for $50 million with the greenshoe on March 4.

The company sold 5,518,630 common shares at $10.00 per share. The price per share reflects an 11.97% discount to the March 3 closing share price of $11.36. Of the shares, 518,630 were part of the fully exercised greenshoe.

Leerink Partners, LLC was the bookrunning manager.

Proceeds will be used for OvaPrimeSM preclinical studies and the anticipated 2015 international launch, to expand the AugmentSM international launch, establish an international subsidiary and for other general corporate purposes.

Based in Cambridge, Mass., OvaScience is a fertility company focused on new treatments for infertility.

Issuer:	OvaScience, Inc.
Issue:	Common stock
Amount:	$55,186,300, including $5,186,300 greenshoe
Shares:	5,518,630
Price:	$10.00
Warrants:	No
Bookrunner:	Leerink Partners, LLC
Co-managers:	Cantor Fitzgerald & Co., H.C. Wainwright & Co., LLC, JMP Securities LLC, Ladenburg Thalmann & Co. and Roth Capital Partners
Announcement date:	March 3
Pricing date:	March 4
Settlement date:	March 18
Stock symbol:	Nasdaq: OVAS
Stock price:	$11.36 at close March 3
Market capitalization:	$174.36 million

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.